reported the results of a randomized controlled trial showing a dramatic reduction in all
Conclusions: Clarithromycin may have the additional clinical benefit of improving fever
These results suggest that clarithromycin may inhibit seasonal human influenza virus
}, author={Kazuhiro Yatera and Kenji Umeki and Kei Yamasaki and Shingo Noguchi and Chinatsu Nishida and Hiroshi Ishimoto and Noriho Sakamoto and Hiroshi Ishii and
Clarithromycin may modulate airway inflammation in influenza virus infection
Azithromycin and clarithromycin are both antibiotics, but they belong to different classes and have different spectrums of activity
Most of the epidemics and outbreaks of flu are caused by types A and B, whereas type C is generally responsible for sporadic mild upper respiratory symptoms
2% 30-day mortality, P =
9179528
5 to 60
The macrolide clarithromycin (CAM) is used to treat bacterial infections and has anti-inflammatory and immunomodulatory activities
Meningitis and bacteremia due to type b strains occur in areas where the protein-conjugated type b vaccine is not in use, whereas nontypeable strains are major causes of otitis media, sinusitis, acute exacerbations of chronic
The person is in an 'at risk' group The information on this page should be considered current for the 2023-2024 influenza season for clinical practice regarding the use of influenza antiviral medications
Although evidence-based medical management strategies can alter the clinical trajectory of acute respiratory distress syndrome and improve outcomes, critical